[Federal Register Volume 84, Number 109 (Thursday, June 6, 2019)]
[Notices]
[Page 26446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11878]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: American 
Radiolabeled Chem

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before August 5, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 7, 2019, American Radiolabeled Chem, 101 Arc 
Drive, Saint Louis, Missouri 63146 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..........            2010  I
Ibogaine...........................            7260  I
Lysergic acid diethylamide.........            7315  I
Tetrahydrocannabinols..............            7370  I
Dimethyltryptamine.................            7435  I
1-[1-(2-                                       7470  I
 Thienyl)cyclohexyl]piperidine.
Dihydromorphine....................            9145  I
Heroin.............................            9200  I
Normorphine........................            9313  I
Amphetamine........................            1100  II
Methamphetamine....................            1105  II
Amobarbital........................            2125  II
Phencyclidine......................            7471  II
Phenylacetone......................            8501  II
Cocaine............................            9041  II
Codeine............................            9050  II
Dihydrocodeine.....................            9120  II
Oxycodone..........................            9143  II
Hydromorphone......................            9150  II
Ecgonine...........................            9180  II
Hydrocodone........................            9193  II
Meperidine.........................            9230  II
Metazocine.........................            9240  II
Methadone..........................            9250  II
Dextropropoxyphene, bulk (non-                 9273  II
 dosage forms).
Morphine...........................            9300  II
Oripavine..........................            9330  II
Thebaine...........................            9333  II
Oxymorphone........................            9652  II
Phenazocine........................            9715  II
Carfentanil........................            9743  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the above-
listed controlled substances as radiolabeled compounds for biochemical 
research.

    Dated: May 24, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-11878 Filed 6-5-19; 8:45 am]
 BILLING CODE 4410-09-P